This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To investigate whether secondary impairment of the transmethylation pathway is a mechanism underlying the neurologic involvement in homocystinuria due to remethylation defects.
Methods: Twelve patients with neurologic disease due to remethylation defects were examined by brain magnetic resonance spectroscopic imaging (1H MRSI). Brain N-acetylaspartate, choline-containing compounds (Cho), and creatine (Cr) were quantified and compared to with controls. Metabolites of remethylation cycle and creatine biosynthesis pathway were measured in plasma and urine.
Results: MRSI revealed isolated Cho deficiency in all regions examined (mean concentration units ± SD, patients vs controls): frontal white matter (0.051 ± 0.010 vs 0.064 ± 0.010; p = 0.001), lenticular nucleus (0.056 ± 0.011 vs 0.069 ± 0.009; p < 0.001), and thalamus (0.063 ± 0.010 vs 0.071 ± 0.007; p = 0.006). In contrast to controls, the Cho/Cr ratio decreased with age in patients in the three brain regions examined. Low creatine urinary excretion (p < 0.005), normal urine and plasma guanidinoacetate, and a paradoxical increase in plasma S-adenosylmethionine (p < 0.005) concentrations were observed.
Conclusion: Patients with homocystinuria due to remethylation defects have an isolated brain choline deficiency, probably secondary to depletion of labile methyl groups produced by the transmethylation pathway. Although biochemical studies suggest mild peripheral creatine deficiency, brain creatine is in the reference range, indicating a possible compartmentation phenomenon. Paradoxical increase of S-adenosylmethionine suggests that secondary inhibition of methylases contributes to the transmethylation defect in these conditions.
Glossary
- CblC=
- combined homocystinuria-methylmalonic aciduria;
- CblG=
- methionine synthase deficiency;
- CBS=
- cystathionine β-synthase;
- Cho=
- water-soluble choline-containing compounds;
- Cr=
- creatine;
- DQ=
- developmental quotient;
- Met=
- plasma methionine;
- MR=
- magnetic resonance;
- MSRI=
- magnetic resonance spectroscopic imaging;
- MTHFR=
- methylene tetrahydrofolate reductase;
- NA=
- not available;
- NAA=
- N-acetylaspartate;
- NN=
- neonatal;
- NS=
- not significant;
- OA=
- optic atrophy;
- OMA=
- oculomotor apraxia;
- OMIM=
- Online Mendelian Inheritance in Man;
- PM=
- pigmentary maculopathy;
- Pt=
- patient;
- RD=
- remethylation defect;
- RP=
- retinitis pigmentosa;
- tHcy=
- plasma total homocysteine;
- THF=
- tetrahydrofolate.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.